Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Thomas Powles(Queen Mary University of London), Felipe Reyes, D. Cascallar, Mahmoud Abdelsalam, Matias Molina, Christof Vulsteke(University of Antwerp), Şeyda Gündüz(Istinye University), Christian Caglevic, Nobuaki Matsubara(National Cancer Center Hospital East), Marie Vanhuyse, Liane Rapatoni, Mustafa Özgüroğlu(Istanbul University-Cerrahpaşa), Agustín Falco, Yohann Loriot(Institut Gustave Roussy), Gabriela Gatica, Susanna Cheng, Ajjai Alva(Michigan Medicine), Mauricio Fernández Lazzaro, Ronac Mamtani(Hospital of the University of Pennsylvania), Stéphane Oudard(Assistance Publique – Hôpitaux de Paris), Carlos Dzik, Sérgio Jobim Azevedo(Hospital de Clínicas de Porto Alegre), Tibor Csőszi, Rafael Morales‐Barrera(Universitat Autònoma de Barcelona), Yves Fradet(Centre hospitalier universitaire de Québec), Brieuc Sautois(Centre Hospitalier Universitaire de Liège), André P. Fay(Hospital São Lucas da PUCRS), Blanca Homet Moreno(Merck & Co., Inc., Rahway, NJ, USA (United States)), João Paulo Holanda Soares, Evan Y. Yu(University of Washington), Diego Kaen(National University of La Rioja), Alejo Rodríguez‐Vida(Hospital Del Mar), Lajos Géczi(National Institute of Oncology), Denis Schallier, Kentaro Imai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joel Gingerich, Kijoeng Nam(Merck & Co., Inc., Rahway, NJ, USA (United States)), GISELE LOPES MARINHO, David Hugo Flores, Kylea Potvin, Leandro Brust, Mirta Varela, Cristiano Ferrario(Jewish General Hospital), Jean‐Pascal Machiels(Cliniques Universitaires Saint-Luc), Jamile Almeida Silva, F. Van Aelst, Aude Fléchon(Institut Català d'Ornitologia)
Cited by 645
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k